Delivery Order SPE2DB25D7056-SPE2DB25FTMLB
- Not listed
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,055.23, is for the delivery of Varenicline 1 mg tablets over a term ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency awarded a $7,432.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $2,360.02 and a firm fixed price structure. This is a non-set-aside competitively awarded contract with an ultimate completion date of July 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value transaction...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a $3,061.08 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 56 tablets of the drug varenicline 1 mg. This order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Varenicline 1mg tablets in a 56-count package at a ceiling value of $3,841.20. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.94 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 0.5 mg. The award has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 56 tablets of Varenicline 1 mg on September 24, 2025, with completion expected by September 25, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The company, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,316.60 to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packages) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMLBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables delivery of a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support defense and federal civilian healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 5/22/25 |